Pharma Mar Overview

  • Founded
  • 1986
  • Status
  • Public
  • Employees
  • 487
  • Stock Symbol
  • PHM
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $101.69
  • (As of Friday Closing)

Pharma Mar General Information


Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
Primary Office
  • Avda. De los Reyes, 1
  • Pol. Ind. La Mina-Nort
  • 28770 Colmenar Viejo
  • Spain
+34 918 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharma Mar Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$101.69 $104.41 $33.78 - $173.25 $1.85B 18.1M 253K $8.90

Pharma Mar Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 2,111,900 949,099 350,608 728,245
Revenue 274,792 96,070 128,357 179,148
EBITDA 163,220 (10,932) (11,207) (14,756)
Net Income 164,187 (12,738) (6,532) (30,163)
Total Assets 387,122 139,691 180,366 225,208
Total Debt 70,764 96,464 106,846 119,973
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharma Mar Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharma Mar‘s full profile, request access.

Request a free trial

Pharma Mar Executive Team (6)

Name Title Board Seat Contact Info
José Sousa-Faro Ph.D Co-Founder, President, Board Member and Chief Executive Officer
Maria Caballero Chief Financial Officer
Pascal Besman Chief Operating Officer
Juan Carretero Co-Founder
José Jimeno Ph.D Vice President Global Head, Virology Unit
You’re viewing 5 of 6 executive team members. Get the full list »

Pharma Mar Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharma Mar Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Dec-2014 000000000000000000 Biotechnology
To view Pharma Mar’s complete acquisitions history, request access »